InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-09-25 | Julie Johnson(D-TX32) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Dialysis patient service revenues | $13.01B+6.1% | $12.26B+5.9% | $11.57B+3.6% | $11.18B-0.3% | $11.21B |
| Other revenues | $635.9M+14.5% | $555.2M-1.8% | $565.2M+30.4% | $433.4M+6.9% | $405.3M |
| Total revenues | $13.64B+6.5% | $12.82B+5.6% | $12.14B+4.6% | $11.61B-0.1% | $11.62B |
| Patient care costs | $9.24B+7.5% | $8.60B+3.4% | $8.32B+1.3% | $8.21B+3.0% | $7.97B |
| General and administrative | $1.67B+8.8% | $1.54B+4.4% | $1.47B+8.8% | $1.36B+13.4% | $1.20B |
| Depreciation and amortization | $715.3M-1.2% | $723.9M-2.9% | $745.4M+1.8% | $732.6M+7.6% | $680.6M |
| Equity investment income, net | -$33.0M-26.0% | -$26.2M+6.0% | -$27.9M-5.1% | -$26.5M+1.5% | -$26.9M |
| Goodwill impairment charges | $0 | $0-100.0% | $26.1M | $0 | — |
| Gain on changes in ownership interests | $0+100.0% | -$109.5M | $0 | $0 | — |
| Total operating expenses | $11.60B+8.2% | $10.73B+1.8% | $10.54B+2.6% | $10.27B+4.6% | $9.82B |
| Operating income | $2.04B-2.2% | $2.09B+30.4% | $1.60B+19.7% | $1.34B-25.5% | $1.80B |
| Debt expense | -$579.9M-23.3% | -$470.5M-18.0% | -$398.6M-11.6% | -$357.0M-25.2% | -$285.3M |
| Debt extinguishment and modification costs | -$14.2M+28.4% | -$19.8M-148.8% | -$8.0M | — | — |
| Other loss, net | -$102.7M-47.1% | -$69.8M-264.0% | -$19.2M-21.6% | -$15.8M | — |
| Income from continuing operations before income taxes | $1.35B-12.0% | $1.53B+30.0% | $1.18B+21.8% | $966.3M-36.4% | $1.52B |
| Income tax expense | $293.1M+4.8% | $279.7M+27.0% | $220.1M+11.1% | $198.1M-35.4% | $306.7M |
| Net income from continuing operations | $721.8M-22.9% | $936.3M+35.4% | $691.5M+26.4% | $546.9M-44.1% | $978.5M |
| Net income from discontinued operations, net of tax | $25.0M | $0 | $0-100.0% | $13.5M | $0 |
| Net income | $1.08B-13.8% | $1.25B+30.7% | $957.0M+22.4% | $781.6M-35.5% | $1.21B |
| Less: Net income attributable to noncontrolling interests | -$331.9M-5.6% | -$314.4M-18.4% | -$265.4M-20.0% | -$221.2M+5.2% | -$233.3M |
| Net income attributable to DaVita Inc. | $746.8M-20.2% | $936.3M+35.4% | $691.5M+23.4% | $560.4M-42.7% | $978.5M |
| Basic net income from continuing operations | $10K-11.8% | $11K+44.6% | $8K+29.6% | $6K-36.8% | $9K |
| Basic net income | $10K-8.7% | $11K+44.6% | $8K+26.4% | $6K-35.2% | $9K |
| Diluted net income from continuing operations | $10K-11.4% | $11K+44.6% | $7K+29.9% | $6K-35.8% | $9K |
| Diluted net income | $10K-8.3% | $11K+44.6% | $7K+26.8% | $6K-34.3% | $9K |
| Basic shares (in shares) | $74.23B-12.7% | $84.99B-6.4% | $90.79B-2.4% | $92.99B-11.6% | $105.23B |
| Diluted shares (in shares) | $75.89B-13.0% | $87.27B-6.3% | $93.18B-2.8% | $95.83B-12.8% | $109.95B |
| Net income from continuing operations | $721.8M-22.9% | $936.3M+35.4% | $691.5M+26.4% | $546.9M-44.1% | $978.5M |
| Net income from discontinued operations | $25.0M | $0 | $0-100.0% | $13.5M | $0 |
| Net income attributable to DaVita Inc. | $746.8M-20.2% | $936.3M+35.4% | $691.5M+23.4% | $560.4M-42.7% | $978.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Can Execution and Volume Trends Support DaVita's Q1 Earnings?
Here is What to Know Beyond Why DaVita Inc. (DVA) is a Trending Stock
Encompass Health (EHC) Q1 Earnings and Revenues Surpass Estimates
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note